Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis
2017 ◽
Vol 31
(4)
◽
pp. 773-779
◽
1998 ◽
Vol 179
(6)
◽
pp. 1479-1484
◽
2013 ◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 1565-1565
2004 ◽
Vol 12
(6)
◽
pp. 287-298
◽